Hypoxia-inducible factor 2 regulates hepatic lipid metabolism

Molecular and Cellular Biology

Volumn 29, Issue 16, 2009, Pages 4527-4538

  Rankin, Erinn B ^a,e   Rha, Jennifer ^a   Selak, Mary A ^b   Unger, Travis L ^a   Keith, Brian ^c   Liu, Qingdu ^a,d   Haase, Volker H ^a,d  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^e STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 2; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FATTY ACID OXIDATION; FATTY LIVER; GENE EXPRESSION; GLUCONEOGENESIS; HISTOPATHOLOGY; LIPID METABOLISM; LIPID STORAGE; LIPOGENESIS; LIVER METABOLISM; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CLUSTER ANALYSIS; FATTY LIVER; GENE EXPRESSION PROFILING; GLUCONEOGENESIS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; LIPID METABOLISM; LIVER; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, TRANSGENIC; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; VON HIPPEL-LINDAU TUMOR SUPPRESSOR PROTEIN;

MAMMALIA;

EID: 68949098346     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.00200-09     Document Type: Article

References (55)

1. Bruder, E. D., P. C. Lee, and H. Raff. 2005. Lipid and fatty acid profiles in the brain, liver, and stomach contents of neonatal rats: effects of hypoxia. Am. J. Physiol. Endocrinol. Metab. 288:E314-E320.
2. Brunt, E. M., B. A. Neuschwander-Tetri, D. Oliver, K. R. Wehmeier, and B. R. Bacon. 2004. Nonalcoholic steatohepatitis: histologic features and clinical correlations with 30 blinded biopsy specimens. Hum. Pathol. 35: 1070-1082.
3. Chakravarthy, M. V., Z. Pan, Y. Zhu, K. Tordjman, J. G. Schneider, T. Coleman, J. Turk, and C. F. Semenkovich. 2005. "New" hepatic fat activates PPARalpha to maintain glucose, lipid, and cholesterol homeostasis. Cell Metab. 1:309-322.
4. Chang, B. H., L. Li, A. Paul, S. Taniguchi, V. Nannegari, W. C. Heird, and L. Chan. 2006. Protection against fatty liver but normal adipogenesis in mice lacking adipose differentiation-related protein. Mol. Cell. Biol. 26:1063-1076.
5. Das, D. K., J. Ayromlooi, and A. Neogi. 1983. Effect of ischemia on fatty acid metabolism in fetal lung. Life Sci. 33:569-576.
6. Folch, J., M. Lees, and G. H. S. Stanley. 1957. A simple method for the isolation and purification of total lipids from animal tissues. J. Biol. Chem. 226:497-509.
7. Fukumoto, S., and T. Fujimoto. 2002. Deformation of lipid droplets in fixed samples. Histochem. Cell Biol. 118:423-428.
8. Gruber, M., C. J. Hu, R. S. Johnson, E. J. Brown, B. Keith, and M. C. Simon. 2007. Acute postnatal ablation of Hif-2alpha results in anemia. Proc. Natl. Acad. Sci. USA 104:2301-2306.
9. Gulick, T., S. Cresci, T. Caira, D. D. Moore, and D. P. Kelly. 1994. The peroxisome proliferator-activated receptor regulates mitochondrial fatty acid oxidative enzyme gene expression. Proc. Natl. Acad. Sci. USA 91:11012-11016.
10. Haase, V. H., J. N. Glickman, M. Socolovsky, and R. Jaenisch. 2001. Vascular tumors in livers with targeted inactivation of the von Hippel-Lindau tumor suppressor. Proc. Natl. Acad. Sci. USA 98:1583-1588.
11. Hamaguchi, T., N. Iizuka, R. Tsunedomi, Y. Hamamoto, T. Miyamoto, M. Iida, Y. Tokuhisa, K. Sakamoto, M. Takashima, T. Tamesa, and M. Oka. 2008. Glycolysis module activated by hypoxia-inducible factor 1alpha is related to the aggressive phenotype of hepatocellular carcinoma. Int. J. Oncol. 33:725-731.
12. Hu, C. J., L. Y. Wang, L. A. Chodosh, B. Keith, and M. C. Simon. 2003. Differential roles of hypoxia-inducible factor 1α (HIF-1α) and HIF-2α in hypoxic gene regulation. Mol. Cell. Biol. 23:9361-9374.
13. Huss, J. M., F. H. Levy, and D. P. Kelly. 2001. Hypoxia inhibits the peroxisome proliferator-activated receptor alpha/retinoid X receptor gene regulatory pathway in cardiac myocytes: a mechanism for O2-dependent modulation of mitochondrial fatty acid oxidation. J. Biol. Chem. 276:27605-27612.
14. Imai, Y., G. M. Varela, M. B. Jackson, M. J. Graham, R. M. Crooke, and R. S. Ahima. 2007. Reduction of hepatosteatosis and lipid levels by an adipose differentiation-related protein antisense oligonucleotide. Gastroenterology 132:1947-1954.
15. Imamura, M., T. Inoguchi, S. Ikuyama, S. Taniguchi, K. Kobayashi, N. Nakashima, and H. Nawata. 2002. ADRP stimulates lipid accumulation and lipid droplet formation in murine fibroblasts. Am. J. Physiol. Endocrinol. Metab. 283:E775-E783.
16. Jungermann, K. 1988. Metabolic zonation of liver parenchyma. Semin. Liver Dis. 8:329-341.
17. Jungermann, K., and T. Kietzmann. 2000. Oxygen: modulator of metabolic zonation and disease of the liver. Hepatology 31:255-260.
18. Kersten, S., J. Seydoux, J. M. Peters, F. J. Gonzalez, B. Desvergne, and W. Wahli. 1999. Peroxisome proliferator-activated receptor alpha mediates the adaptive response to fasting. J. Clin. Investig. 103:1489-1498.
19. Kim, J. W., I. Tchernyshyov, G. L. Semenza, and C. V. Dang. 2006. HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia. Cell Metab. 3:177-185.
20. Kim, W. Y., and W. G. Kaelin. 2004. Role of VHL gene mutation in human cancer. J. Clin. Oncol. 22:4991-5004.
21. Kinnula, V. L., and I. Hassinen. 1978. Effect of chronic hypoxia on hepatic triacylglycerol concentration and mitochondrial fatty acid oxidizing capacity in liver and heart. Acta Physiol. Scand. 102:64-73.
22. Koo, S. H., H. Satoh, S. Herzig, C. H. Lee, S. Hedrick, R. Kulkarni, R. M. Evans, J. Olefsky, and M. Montminy. 2004. PGC-1 promotes insulin resistance in liver through PPAR-alpha-dependent induction of TRB-3. Nat. Med. 10:530-534.
23. Lefebvre, P., G. Chinetti, J. C. Fruchart, and B. Staels. 2006. Sorting out the roles of PPAR alpha in energy metabolism and vascular homeostasis. J. Clin. Investig. 116:571-580.
24. Leone, T. C., C. J. Weinheimer, and D. P. Kelly. 1999. A critical role for the peroxisome proliferator-activated receptor alpha (PPARalpha) in the cellular fasting response: the PPARalpha-null mouse as a model of fatty acid oxidation disorders. Proc. Natl. Acad. Sci. USA 96:7473-7478.
25. Londos, C., C. Sztalryd, J. T. Tansey, and A. R. Kimmel. 2005. Role of PAT proteins in lipid metabolism. Biochimie 87:45-49.
26. Magana, M. M., S. H. Koo, H. C. Towle, and T. F. Osborne. 2000. Different sterol regulatory element-binding protein-1 isoforms utilize distinct co-regulatory factors to activate the promoter for fatty acid synthase. J. Biol. Chem. 275:4726-4733.
27. Magana, M. M., and T. F. Osborne. 1996. Two tandem binding sites for sterol regulatory element binding proteins are required for sterol regulation of fatty-acid synthase promoter. J. Biol. Chem. 271:32689- 32694.
28. Mandard, S., M. Muller, and S. Kersten. 2004. Peroxisome proliferator-activated receptor alpha target genes. Cell. Mol. Life Sci. 61:393-416.
29. Maynard, M. A., H. Qi, J. Chung, E. H. Lee, Y. Kondo, S. Hara, R. C. Conaway, J. W. Conaway, and M. Ohh. 2003. Multiple splice variants of the human HIF-3alpha locus are targets of the von Hippel-Lindau E3 ubiquitin ligase complex. J. Biol. Chem. 278:11032-11040.
30. Moore, K. H., J. F. Radloff, F. E. Hull, and C. C. Sweeley. 1980. Incomplete fatty acid oxidation by ischemic heart: beta-hydroxy fatty acid production. Am. J. Physiol. 239:H257-H265.
31. Narravula, S., and S. P. Colgan. 2001. Hypoxia-inducible factor 1-mediated inhibition of peroxisome proliferator-activated receptor alpha expression during hypoxia. J. Immunol. 166:7543-7548.
32. Olofsson, S. O., P. Bostrom, L. Andersson, M. Rutberg, J. Perman, and J. Boren. 2009. Lipid droplets as dynamic organelles connecting storage and efflux of lipids. Biochim. Biophys. Acta 1791:448-458.
33. Papandreou, I., R. A. Cairns, L. Fontana, A. L. Lim, and N. C. Denko. 2006. HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption. Cell Metab. 3:187-197.
34. Postic, C., M. Shiota, K. D. Niswender, T. L. Jetton, Y. Chen, J. M. Moates, K. D. Shelton, J. Lindner, A. D. Cherrington, and M. A. Magnuson. 1999. Dual roles for glucokinase in glucose homeostasis as determined by liver and pancreatic beta cell-specific gene knock-outs using Cre recombinase. J. Biol. Chem. 274:305-315.
35. Rankin, E. B., M. P. Biju, Q. Liu, T. L. Unger, J. Rha, R. S. Johnson, M. C. Simon, B. Keith, and V. H. Haase. 2007. Hypoxia-inducible factor-2 (HIF-2) regulates hepatic erythropoietin in vivo. J. Clin. Investig. 117:1068-1077.
36. Rankin, E. B., D. F. Higgins, J. A. Walisser, R. S. Johnson, C. A. Bradfield, and V. H. Haase. 2005. Inactivation of the arylhydrocarbon receptor nuclear translocator (Arnt) suppresses von Hippel-Lindau disease-associated vascular tumors in mice. Mol. Cell. Biol. 25:3163-3172.
37. Rankin, E. B., J. Rha, T. L. Unger, C. H. Wu, H. P. Shutt, R. S. Johnson, M. C. Simon, B. Keith, and V. H. Haase. 2008. Hypoxia-inducible factor-2 regulates vascular tumorigenesis in mice. Oncogene 27:5354-5358.
38. Rankin, E. B., J. E. Tomaszewski, and V. H. Haase. 2006. Renal cyst development in mice with conditional inactivation of the von Hippel-Lindau tumor suppressor. Cancer Res. 66:2576-2583.
39. Reddy, J. K., and T. Hashimoto. 2001. Peroxisomal beta-oxidation and peroxisome proliferator-activated receptor alpha: an adaptive metabolic system. Annu. Rev. Nutr. 21:193-230.
40. Rhee, J., Y. Inoue, J. C. Yoon, P. Puigserver, M. Fan, F. J. Gonzalez, and B. M. Spiegelman. 2003. Regulation of hepatic fasting response by PPAR-gamma coactivator-1alpha (PGC-1): requirement for hepatocyte nuclear factor 4alpha in gluconeogenesis. Proc. Natl. Acad. Sci. USA 100:4012-4017.
41. Ryan, H. E., M. Poloni, W. McNulty, D. Elson, M. Gassmann, J. M. Arbeit, and R. S. Johnson. 2000. Hypoxia-inducible factor-1alpha is a positive factor in solid tumor growth. Cancer Res. 60:4010-4015.
42. Schofield, C. J., and P. J. Ratcliffe. 2004. Oxygen sensing by HIF hydroxylases. Nat. Rev. Mol. Cell Biol. 5:343-354.
43. Schoonjans, K., M. Watanabe, H. Suzuki, A. Mahfoudi, G. Krey, W. Wahli, P. Grimaldi, B. Staels, T. Yamamoto, and J. Auwerx. 1995. Induction of the acyl-coenzyme A synthetase gene by fibrates and fatty acids is mediated by a peroxisome proliferator response element in the C promoter. J. Biol. Chem. 270:19269-19276.
44. Seagroves, T. N., H. E. Ryan, H. Lu, B. G. Wouters, M. Knapp, P. Thibault, K. Laderoute, and R. S. Johnson. 2001. Transcription factor HIF-1 is a necessary mediator of the Pasteur effect in mammalian cells. Mol. Cell. Biol. 21:3436-3444.
45. Semenza, G. L. 1999. Regulation of mammalian O2 homeostasis by hypoxiainducible factor 1. Annu. Rev. Cell Dev. Biol. 15:551-578.
46. Semenza, G. L., P. H. Roth, H. M. Fang, and G. L. Wang. 1994. Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor 1. J. Biol. Chem. 269:23757-23763.
47. Shimano, H., J. D. Horton, I. Shimomura, R. E. Hammer, M. S. Brown, and J. L. Goldstein. 1997. Isoform 1c of sterol regulatory element binding protein is less active than isoform 1a in livers of transgenic mice and in cultured cells. J. Clin. Investig. 99:846-854.
48. Shimomura, I., H. Shimano, B. S. Korn, Y. Bashmakov, and J. D. Horton. 1998. Nuclear sterol regulatory element-binding proteins activate genes responsible for the entire program of unsaturated fatty acid biosynthesis in transgenic mouse liver. J. Biol. Chem. 273:35299-35306.
49. Tanne, F., F. Gagnadoux, O. Chazouilleres, B. Fleury, D. Wendum, E. Lasnier, B. Lebeau, R. Poupon, and L. Serfaty. 2005. Chronic liver injury during obstructive sleep apnea. Hepatology 41:1290-1296.
50. Tugwood, J. D., I. Issemann, R. G. Anderson, K. R. Bundell, W. L. McPheat, and S. Green. 1992. The mouse peroxisome proliferator activated receptor recognizes a response element in the 5′ flanking sequence of the rat acyl CoA oxidase gene. EMBO J. 11:433-439.
51. Wenger, R. H. 2002. Cellular adaptation to hypoxia: O2-sensing protein hydroxylases, hypoxia-inducible transcription factors, and O2-regulated gene expression. FASEB J. 16:1151-1162.
52. White, P., J. E. Brestelli, K. H. Kaestner, and L. E. Greenbaum. 2005. Identification of transcriptional networks during liver regeneration. J. Biol. Chem. 280:3715-3722.
53. Whitmer, J. T., J. A. Idell-Wenger, M. J. Rovetto, and J. R. Neely. 1978. Control of fatty acid metabolism in ischemic and hypoxic hearts. J. Biol. Chem. 253:4305-4309.
54. Yoon, J. C., P. Puigserver, G. Chen, J. Donovan, Z. Wu, J. Rhee, G. Adelmant, J. Stafford, C. R. Kahn, D. K. Granner, C. B. Newgard, and B. M. Spiegelman. 2001. Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1. Nature 413:131-138.
55. Zhang, H., P. Gao, R. Fukuda, G. Kumar, B. Krishnamachary, K. I. Zeller, C. V. Dang, and G. L. Semenza. 2007. HIF-1 inhibits mitochondrial biogenesis and cellular respiration in VHL-deficient renal cell carcinoma by repression of C-MYC activity. Cancer Cell 11:407-420.